VREX (Varex Imaging Corporation Common Stock) Stock Analysis - Hedge Fund Holdings
Varex Imaging Corporation Common Stock (VREX) is a publicly traded Healthcare sector company. As of May 21, 2026, VREX trades at $9.20 with a market cap of $408.82M and a P/E ratio of -5.03. VREX moved +8.48% today. Year to date, VREX is -17.71%; over the trailing twelve months it is +24.45%. Its 52-week range spans $6.76 to $16.93. Analyst consensus is buy with an average price target of $18.00. Rallies surfaces VREX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns VREX stock?
Hedge funds tracked by Rallies that own VREX include Panagora Asset and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Varex Imaging Corporation Common Stock.
VREX Key Metrics
Key financial metrics for VREX
Metric
Value
Price
$9.20
Market Cap
$408.82M
P/E Ratio
-5.03
EPS
$-1.99
Dividend Yield
0.00%
52-Week High
$16.93
52-Week Low
$6.76
Volume
2
Avg Volume
0
Revenue (TTM)
$857.50M
Net Income
$-82.50M
Gross Margin
33.55%
Top Hedge Funds Holding VREX
Panagora Asset holds 295.54K shares of VREX, changed +95.42% as of Mar 31, 2026.
Bridgewater Associates holds 33.19K shares of VREX, changed +16.14% as of Jun 30, 2024.
Hedge funds tracked by Rallies that own VREX include Panagora Asset and Bridgewater Associates. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Varex Imaging Corporation Common Stock.
Does Rallies show 13F holders for VREX?
Yes. Rallies tracks hedge fund and 13F ownership data for VREX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VREX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VREX. It does not provide personalized investment advice.